ABCL
Price
$4.34
Change
-$0.13 (-2.91%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
1.34B
57 days until earnings call
PRME
Price
$4.01
Change
-$0.06 (-1.47%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
725.58M
46 days until earnings call
Interact to see
Advertisement

ABCL vs PRME

Header iconABCL vs PRME Comparison
Open Charts ABCL vs PRMEBanner chart's image
AbCellera Biologics
Price$4.34
Change-$0.13 (-2.91%)
Volume$45.35K
Capitalization1.34B
Prime Medicine
Price$4.01
Change-$0.06 (-1.47%)
Volume$23.63K
Capitalization725.58M
ABCL vs PRME Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRME commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and PRME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (ABCL: $4.47 vs. PRME: $4.07)
Brand notoriety: ABCL and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 56% vs. PRME: 69%
Market capitalization -- ABCL: $1.34B vs. PRME: $725.58M
ABCL [@Biotechnology] is valued at $1.34B. PRME’s [@Biotechnology] market capitalization is $725.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • PRME’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ABCL and PRME are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +5.92% price change this week, while PRME (@Biotechnology) price change was +9.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.53%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +34.29%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

PRME is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (+3.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.34B) has a higher market cap than PRME($726M). ABCL YTD gains are higher at: 52.560 vs. PRME (39.384). PRME (-197.38M) and ABCL (-197.92M) have comparable annual earnings (EBITDA) . ABCL has more cash in the bank: 553M vs. PRME (102M). PRME has less debt than ABCL: PRME (120M) vs ABCL (142M). ABCL has higher revenues than PRME: ABCL (32.9M) vs PRME (4.96M).
ABCLPRMEABCL / PRME
Capitalization1.34B726M184%
EBITDA-197.92M-197.38M100%
Gain YTD52.56039.384133%
P/E RatioN/AN/A-
Revenue32.9M4.96M663%
Total Cash553M102M542%
Total Debt142M120M118%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLPRME
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TAAEX47.540.53
+1.13%
Transamerica Capital Growth R
RYMRX22.54-0.03
-0.13%
Guggenheim Multi-Hedge Strategies C
TRZKX77.76-0.17
-0.22%
T. Rowe Price International Discovery Z
MFCAX41.12-0.36
-0.87%
Meridian Contrarian A
DRISX19.24-0.19
-0.98%
North Square Small Cap Value I

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-3.04%
RXRX - ABCL
58%
Loosely correlated
-0.41%
CRSP - ABCL
56%
Loosely correlated
+0.66%
VCYT - ABCL
56%
Loosely correlated
-3.08%
ABSI - ABCL
53%
Loosely correlated
-6.93%
BEAM - ABCL
51%
Loosely correlated
-4.41%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-0.25%
CRSP - PRME
57%
Loosely correlated
+0.66%
BEAM - PRME
53%
Loosely correlated
-4.41%
RXRX - PRME
53%
Loosely correlated
-0.41%
CRBU - PRME
47%
Loosely correlated
-5.76%
EDIT - PRME
46%
Loosely correlated
-0.74%
More